166 related articles for article (PubMed ID: 2514343)
21. Effects of estradiol and tamoxifen on creatine kinase in rodent mammary carcinomas.
Roghmann MC; Skinner KA; Hilf R
Cancer Res; 1987 Mar; 47(5):1348-53. PubMed ID: 3102045
[TBL] [Abstract][Full Text] [Related]
22. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
23. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
24. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
25. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
26. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
27. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
[TBL] [Abstract][Full Text] [Related]
28. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
29. [Increased activity of choline kinase in human breast cancer and 7, 12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary carcinoma, and activated by 17 beta-estradiol: preliminary report].
Koibuchi Y; Iino Y; Sugamata N; Takai Y; Morishita Y; Uchida T; Yamashita S
Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1318. PubMed ID: 8272074
[No Abstract] [Full Text] [Related]
30. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
Lunenfeld B; Geier A
Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
[TBL] [Abstract][Full Text] [Related]
31. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
32. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
[TBL] [Abstract][Full Text] [Related]
33. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
34. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
[TBL] [Abstract][Full Text] [Related]
35. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
Wei LL; Mangel WF; Katzenellenbogen BS
J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
[TBL] [Abstract][Full Text] [Related]
36. [A hormonal impact on DMBA-induced rat ovarian cancer--detection of estrogen receptors, and resultant morphologic changes after estrogen application].
Katabuchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1634-40. PubMed ID: 6413623
[TBL] [Abstract][Full Text] [Related]
37. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of tamoxifen in laboratory animals.
Jordan VC; Allen KE; Dix CJ
Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
[TBL] [Abstract][Full Text] [Related]
40. On the mechanism of prolactin and estrogen action in 7,12 dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptor.
Leung BS; Sasaki GH
Endocrinology; 1975 Sep; 97(3):564-72. PubMed ID: 170065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
